Pills According to arepresentative for one trade group, big pharma firms are playing"patent games to protect profits and prevent competition." (Photo:Getty)

Federal regulators have approved a record number of new generic medications in each of the last threeyears, but many of the new drugs are not making it to market.

Iqvia, a health research firm, reports that more than a third ofthe nearly 2,500 generic drugs approved since 2016 are available toconsumers. Roughly 70 percent of the 442 approved in 2019 remainunavailable.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Health Care Reform
Employer-Paid